Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$680M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
UnitedHealth
UNH
|
+$393M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$381M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.24B |
| 2 |
Tesla
TSLA
|
+$450M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$444M |
| 4 |
TSMC
TSM
|
+$432M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.79% |
| 2 | Consumer Discretionary | 0.82% |
| 3 | Financials | 0.79% |
| 4 | Healthcare | 0.66% |
| 5 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12176
PUT
Stereotaxis
STXS
$140M
| $39.4K | ﹤0.01% |
18,600
-22,000
| -54% | -$44.7K |
|
|
PGYWW
12177
Pagaya Technologies Ltd Warrants
PGYWW
$1.14M
| $39.4K | ﹤0.01% |
231,838
+212,784
| +1,117% | +$27.8K |
|
12178
Alto Ingredients
ALTO
$311M
| $39.2K | ﹤0.01% |
34,053
-469,572
| -93% | -$450K |
|
|
CSCI
12179
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
| $39K | ﹤0.01% |
11,504
-403
| -3% | -$1.34K |
|
12180
CALL
Televisa
TV
$1.47B
| $39K | ﹤0.01% |
+17,800
| New | +$34.9K |
|
12181
Amprius Technologies Warrants
AMPX.WS
$413M
| $38.7K | ﹤0.01% |
+74,433
| New | +$28K |
|
12182
Cumberland Pharmaceuticals
CPIX
$134M
| $38.6K | ﹤0.01% |
11,527
-17,412
| -60% | -$82.5K |
|
12183
Genius Group
GNS
$34.2M
| $38.4K | ﹤0.01% |
28,268
| – | – |
|
12184
CALL
Aemetis
AMTX
$135M
| $38.4K | ﹤0.01% |
15,500
+4,500
| +41% | +$7.61K |
|
12185
PUT
Milestone Pharmaceuticals
MIST
$142M
| $38.4K | ﹤0.01% |
19,800
-12,300
| -38% | -$16.4K |
|
|
SOND
12186
PUT
DELISTED
Sonder
SOND
| $38.3K | ﹤0.01% |
+14,200
| New | +$28.8K |
|
|
ZEPP
12187
PUT
Zepp Health
ZEPP
$75.1M
| $38.3K | ﹤0.01% |
14,400
-2,000
| -12% | -$5.12K |
|
12188
CALL
Rimini Street
RMNI
$479M
| $38.1K | ﹤0.01% |
+10,100
| New | +$33.7K |
|
|
DHY
12189
Credit Suisse High Yield Credit Fund
DHY
$238M
| $37.5K | ﹤0.01% |
17,601
-21,469
| -55% | -$43.8K |
|
12190
PUT
Laser Photonics
LASE
$71.3M
| $37.4K | ﹤0.01% |
+13,900
| New | +$36.4K |
|
12191
CALL
Voyager Therapeutics
VYGR
$214M
| $37.3K | ﹤0.01% |
+12,000
| New | +$38.7K |
|
12192
CALL
SkinHealth Systems
SKIN
$87.6M
| $37.2K | ﹤0.01% |
19,500
-41,300
| -68% | -$58.2K |
|
|
MODV
12193
CALL
DELISTED
ModivCare
MODV
| $37.1K | ﹤0.01% |
+11,900
| New | +$21.9K |
|
|
PTIX
12194
DELISTED
Performance Technologies
PTIX
| $37.1K | ﹤0.01% |
+10,156
| New | +$39K |
|
12195
Deswell Industries
DSWL
$50M
| $37K | ﹤0.01% |
+13,795
| New | +$32.1K |
|
|
RVPH
12196
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
| $36.9K | ﹤0.01% |
4,845
-6,728
| -58% | -$105K |
|
12197
Xcel Brands
XELB
$6.03M
| $36.5K | ﹤0.01% |
+20,180
| New | +$47.5K |
|
12198
CALL
3D Systems Corp
DDD
$533M
| $36.2K | ﹤0.01% |
23,500
-11,100
| -32% | -$20.1K |
|
|
ORIO
12199
Orion Digital Corp
ORIO
$20.1M
| $35.9K | ﹤0.01% |
28,529
+9,632
| +51% | +$10.9K |
|
|
ORGN
12200
PUT
DELISTED
Origin Materials
ORGN
| $35.9K | ﹤0.01% |
2,493
-1,257
| -34% | -$21.3K |
|
Similar funds
Jeff Yass's Q2 2025 Portfolio in Review
As of Q2 2025, Jeff Yass held 14,080 positions worth $720B, up 23% from $586B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass deployed $32.3B of net new capital in Q2 2025, opening 1,720 new positions and adding to 5,716 existing holdings. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 1.8% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.24B trimmed.
- Jeff Yass's largest Q2 2025 buy was iShares Core MSCI Total International Stock ETF: 1,549,778 shares worth $120M.
- Jeff Yass added most to Apple in Q2 2025, an estimated $680M increase.
- Jeff Yass's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.24B.
- Jeff Yass fully exited Vanguard Intermediate-Term Bond ETF in Q2 2025, selling an estimated $61.8M.
- Jeff Yass's ten largest holdings make up 26% of its $720B portfolio in Q2 2025.
- Jeff Yass opened 1,720 new positions and closed 1,538 in Q2 2025.
- Jeff Yass's portfolio value rose 23% quarter-over-quarter to $720B.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.